Clinical Trial Update: Immune Ablation and Stem Cell Support for Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of immune ablation and stem cell support for Crohn's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Crohn Disease | Phase 2 | Status: WITHDRAWN